[go: up one dir, main page]

US20170225123A1 - Inline diafiltration with multi-channel pump - Google Patents

Inline diafiltration with multi-channel pump Download PDF

Info

Publication number
US20170225123A1
US20170225123A1 US15/015,350 US201615015350A US2017225123A1 US 20170225123 A1 US20170225123 A1 US 20170225123A1 US 201615015350 A US201615015350 A US 201615015350A US 2017225123 A1 US2017225123 A1 US 2017225123A1
Authority
US
United States
Prior art keywords
fluid
diafiltration
feed
permeate
passing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US15/015,350
Other versions
US10183108B2 (en
Inventor
Engin Ayturk
Catherine Casey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cytiva US LLC
Original Assignee
Pall Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pall Corp filed Critical Pall Corp
Priority to US15/015,350 priority Critical patent/US10183108B2/en
Assigned to PALL CORPORATION reassignment PALL CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CASEY, Catherine, AYTURK, Engin
Priority to EP17151017.5A priority patent/EP3202484B1/en
Priority to JP2017003672A priority patent/JP6402375B2/en
Priority to SG10201700425WA priority patent/SG10201700425WA/en
Priority to AU2017200496A priority patent/AU2017200496B2/en
Priority to CN201710056870.4A priority patent/CN107029556B/en
Priority to CA2956615A priority patent/CA2956615C/en
Priority to KR1020170013716A priority patent/KR101917663B1/en
Assigned to PALL CORPORATION reassignment PALL CORPORATION CORRECTION BY DECLARATION OF INCORRECT NUMBER 29553358 RECORDED AT REEL/FRAME 037740/0577 Assignors: PALL CORPORATION
Publication of US20170225123A1 publication Critical patent/US20170225123A1/en
Publication of US10183108B2 publication Critical patent/US10183108B2/en
Application granted granted Critical
Assigned to CYTIVA US LLC reassignment CYTIVA US LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: PALL CORPORATION
Active legal-status Critical Current
Adjusted expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3413Diafiltration
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D61/00Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/02Reverse osmosis; Hyperfiltration ; Nanofiltration
    • B01D61/025Reverse osmosis; Hyperfiltration
    • B01D61/026Reverse osmosis; Hyperfiltration comprising multiple reverse osmosis steps
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D61/00Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/02Reverse osmosis; Hyperfiltration ; Nanofiltration
    • B01D61/08Apparatus therefor
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D61/00Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/02Reverse osmosis; Hyperfiltration ; Nanofiltration
    • B01D61/12Controlling or regulating
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D61/00Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14Ultrafiltration; Microfiltration
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D61/00Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14Ultrafiltration; Microfiltration
    • B01D61/145Ultrafiltration
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D61/00Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14Ultrafiltration; Microfiltration
    • B01D61/18Apparatus therefor
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D61/00Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14Ultrafiltration; Microfiltration
    • B01D61/22Controlling or regulating
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D63/00Apparatus in general for separation processes using semi-permeable membranes
    • B01D63/08Flat membrane modules
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D63/00Apparatus in general for separation processes using semi-permeable membranes
    • B01D63/08Flat membrane modules
    • B01D63/082Flat membrane modules comprising a stack of flat membranes
    • B01D63/084Flat membrane modules comprising a stack of flat membranes at least one flow duct intersecting the membranes
    • B01D63/085Flat membrane modules comprising a stack of flat membranes at least one flow duct intersecting the membranes specially adapted for two fluids in mass exchange flow
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/34Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1017Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by filtration, e.g. using filters, frits, membranes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2311/00Details relating to membrane separation process operations and control
    • B01D2311/04Specific process operations in the feed stream; Feed pretreatment
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2311/00Details relating to membrane separation process operations and control
    • B01D2311/06Specific process operations in the permeate stream
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2311/00Details relating to membrane separation process operations and control
    • B01D2311/14Pressure control
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2311/00Details relating to membrane separation process operations and control
    • B01D2311/16Flow or flux control
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2311/00Details relating to membrane separation process operations and control
    • B01D2311/16Flow or flux control
    • B01D2311/165Cross-flow velocity control
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2313/00Details relating to membrane modules or apparatus
    • B01D2313/18Specific valves
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2313/00Details relating to membrane modules or apparatus
    • B01D2313/24Specific pressurizing or depressurizing means
    • B01D2313/243Pumps
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2313/00Details relating to membrane modules or apparatus
    • B01D2313/54Modularity of membrane module elements
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2315/00Details relating to the membrane module operation
    • B01D2315/10Cross-flow filtration
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2315/00Details relating to the membrane module operation
    • B01D2315/12Feed-and-bleed systems
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2315/00Details relating to the membrane module operation
    • B01D2315/16Diafiltration
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2319/00Membrane assemblies within one housing
    • B01D2319/04Elements in parallel

Definitions

  • Diafiltration is a technique that uses ultrafiltration (UF) membranes to remove, replace, or lower the concentration of undesirable materials such as salts and/or solvents from fluids containing desirable materials, for example, desired biomolecules such as proteins, peptides, and nucleic acids.
  • UF membrane retains molecules that are larger than the pores of the membrane (the solution containing the retained molecules is referred to as the retentate or concentrate), and smaller molecules such as salts, solvents, and water (which are 100 % permeable), freely pass through the membrane (providing a solution referred to as the permeate or filtrate).
  • Continuous diafiltration involves washing out the original buffer salts (and/or other low molecular weight species) in the retentate by adding water or new buffer to the retentate at the same rate as filtrate is being generated.
  • the retentate volume and product concentration does not change during the diafiltration process. If water is used for diafiltering, the salts will be washed out and the conductivity lowered. If a buffer is used for diafiltering, the new buffer salt concentration will increase at a rate inversely proportional to that of the species being removed, and the conductivity will be increased. The amount of salt removed is related to the filtrate volume generated, relative to the retentate volume.
  • the filtrate volume generated is usually referred to in terms of “diafiltration volumes.”
  • a single diafiltration volume (DV) is the volume of retentate when diafiltration is started.
  • liquid is added at the same rate as filtrate is generated.
  • the volume of filtrate collected equals the starting retentate volume, 1 DV has been processed.
  • greater than 99.5% of a 100% permeable solute can be removed by washing through 6 retentate volumes ( 6 DV) with the buffer of choice.
  • the present invention provides for ameliorating at least some of the disadvantages of the prior art.
  • An embodiment of the invention provides a diafiltration system comprising (a) a fluid treatment assembly comprising two or more fluid treatment modules, the fluid treatment assembly comprising a feed inlet, and permeate outlet, and a retentate outlet; (i) each fluid treatment module comprising a cross flow treatment assembly including at least one ultrafiltration membrane, the fluid treatment assembly comprising having at least one feed side and at least one opposite permeate side, and a diafiltration fluid distribution plate comprising a diafiltration fluid feed inlet and a common feed permeate/diafiltration fluid permeate outlet port; (b) two or more separate diafiltration fluid conduits, each separate diafiltration fluid conduit in fluid communication with a respective single diafiltration fluid feed inlet; and, (c) a diafiltration fluid pump, the diafiltration fluid pump comprising at least a first multiple channel pump head having at least two channels including separate channels for separate diafiltration fluid conduits in fluid communication with respective single diafiltration fluid feed inlets, wherein the diafiltration pump provides simultaneously controlled diafiltration fluid
  • a method of diafiltration comprising passing a feed fluid containing undesirable material and desirable biomolecules, and a diafiltration fluid suitable for washing out undesirable material from the feed fluid, through the fluid treatment assembly in an embodiment of the diafiltration system, wherein the method includes (a) passing the feed fluid at a controlled feed fluid flow rate through the feed inlet of the fluid treatment assembly; (b) passing the diafiltration fluid at a controlled diafiltration fluid flow rate through each of the separate diafiltration fluid conduits in fluid communication with respective single diafiltration fluid feed inlets, such that the diafiltration fluid washes undesirable material from the feed fluid, wherein the controlled diafiltration fluid flow rate is simultaneously controlled through each of the separate diafiltration fluid conduits; (c) passing a feed permeate/diafiltration fluid permeate fluid through each of the common feed permeate/diafiltration fluid permeate outlet ports; (d) passing a retentate fluid from the retentate outlet of fluid treatment assembly, the retentate fluid comprising
  • FIG. 1A is a diagrammatic view of a diafiltration pump including a plurality of multiple channel pump heads for use in an embodiment of the invention.
  • FIG. 1B is a diagrammatic view of an open multiple channel pump head, illustrating separate channels.
  • FIG. 1C is a schematic view of an embodiment of a diafiltration system according to the present invention, wherein the illustrated diafiltration system comprises a fluid treatment assembly including a plurality of fluid treatment modules, a plurality of diafiltration fluid conduits, and a diafiltration pump including a plurality of multiple channel pump heads.
  • FIG. 2A is an exploded view of an illustrative fluid treatment assembly including a plurality of fluid treatment modules, the fluid treatment modules including cross flow treatment assemblies.
  • FIGS. 2B and 2C show exploded views of a cross flow treatment assembly in a fluid treatment module shown in FIG. 2A .
  • FIG. 2B shows individual components
  • FIG. 2C shows some of the components combined to show sub-assemblies.
  • FIG. 2D shows fluid flow pathways through the fluid treatment assembly shown in FIG. 2A .
  • FIG. 3A and FIG. 3B show top perspective views of exemplary diafiltration fluid distribution plates for use in fluid treatment modules, the plates each including a diafiltration fluid feed inlet, a diafiltration fluid inlet port, a diafiltration fluid feed channel, a diafiltration fluid permeate port, and a diafiltration fluid permeate outlet
  • FIG. 4A is a front view of 2 assembled fluid treatment assemblies including 6 fluid treatment modules, one set of modules including 2 in-series cross flow treatment assemblies, the other set of modules including 3 in-series cross flow treatment assemblies;
  • FIG. 4B is a rear view of the assembled fluid treatment assemblies shown in FIG. 4A , and
  • FIG. 4C shows fluid flow pathways through the fluid treatment assembly including 2 in-series cross flow treatment assemblies shown in FIG. 4A .
  • a diafiltration system comprising (a) a fluid treatment assembly comprising two or more fluid treatment modules, the fluid treatment assembly comprising a feed inlet, and permeate outlet, and a retentate outlet; (i) each fluid treatment module comprising a cross flow treatment assembly including at least one ultrafiltration membrane, the cross flow treatment assembly having at least one feed side and at least one opposite permeate side, and a diafiltration fluid distribution plate comprising a diafiltration fluid feed inlet and a common feed permeate/diafiltration fluid permeate outlet port; (b) two or more separate diafiltration fluid conduits, each separate diafiltration fluid conduit in fluid communication with a respective single diafiltration fluid feed inlet; and, (c) a diafiltration fluid pump, the diafiltration fluid pump comprising at least a first multiple channel pump head having at least two channels including separate channels for separate diafiltration fluid conduits in fluid communication with respective single diafiltration fluid feed inlets, wherein the diafiltration
  • a diafiltration fluid distribution plate comprising a diafiltration fluid feed inlet and the diafiltration fluid feed channel communicating with the diafiltration fluid feed inlet, and a common feed retentate port, wherein the common feed retentate port has 2 different inner diameters.
  • the diafiltration system further comprises a feed fluid pump and a feed fluid conduit, wherein the feed fluid conduit is in fluid communication with the fluid treatment assembly feed inlet, wherein the feed fluid pump provides a controlled feed fluid flow rate through the feed fluid conduit to the fluid treatment assembly feed inlet.
  • the diafiltration system includes at least one additional channel pump head having including a separate channel for a separate diafiltration fluid conduit in fluid communication with a single diafiltration fluid feed inlet, wherein the pump, via the first multiple channel pump head and the additional channel pump head, provides simultaneously controlled diafiltration fluid flow rates through each of the separate diafiltration fluid conduits to the respective single diafiltration fluid feed inlets.
  • an embodiment of the diafiltration system of claim includes at least one additional multiple channel pump head having at least two channels including a separate channel for a separate diafiltration fluid conduit in fluid communication with a single diafiltration fluid feed inlet, wherein the pump, via the first multiple channel pump head and the additional multiple channel pump head, provides simultaneously controlled diafiltration fluid flow rates through each of the separate diafiltration fluid conduits to the respective single diafiltration fluid feed inlets.
  • the diafiltration system further comprises a retentate throttling valve, arranged to allow the system to maintain a desired ratio of feed flow rate to retentate flow rate.
  • a method of diafiltration comprising passing a feed fluid containing undesirable material and desirable biomolecules, and a diafiltration fluid suitable for washing out undesirable material from the feed fluid, through the fluid treatment assembly in an embodiment of the diafiltration system, wherein the method includes (a) passing the feed fluid at a controlled feed fluid flow rate through the feed inlet of the fluid treatment assembly; (b) passing the diafiltration fluid at a controlled diafiltration fluid flow rate through each of the separate diafiltration fluid conduits in fluid communication with respective single diafiltration fluid feed inlets, such that the diafiltration fluid washes undesirable material from the feed fluid, wherein the controlled diafiltration fluid flow rate is simultaneously controlled through each of the separate diafiltration fluid conduits; (c) passing a feed permeate/diafiltration fluid permeate fluid through each of the common feed permeate/diafiltration fluid permeate outlet ports; (d) passing a retentate fluid from the retentate outlet of fluid treatment assembly, the retentate fluid comprising
  • the feed fluid pump provides a controlled feed fluid flow rate through the feed fluid conduit to the fluid treatment assembly feed inlet at a flow rate that is lower than (e.g., at least about 10% lower than) the simultaneously controlled diafiltration fluid flow rates through each of the separate diafiltration fluid conduits provided by the diafiltration pump.
  • the invention is suitable for discontinuous diafiltration (including sequential dilution and volume reduction), and, more preferably, continuous diafiltration, wherein the diafiltration fluid flow rate is managed through a single point of control.
  • continuous diafiltration as conventionally carried out involves the continuous addition of buffer to into the product tank, and the product of interest (e.g., desirable proteins) is recirculated within the system
  • embodiments of the invention can encompass “continuous diafiltration in its entirety,” such that the product of interest is not recirculated within the system; rather, it is processed continuously in a single-pass mode of operation.
  • Fluids can be passed through the fluid treatment assembly in co-current and counter-current flow directions, in a single-pass mode or a continuous-pass mode.
  • Fluid treatment assemblies can include any number of fluid treatment modules (e.g., “stages,” such as 2, 3, 4, 5, 6, 7, or more, stages), wherein an individual module (stage) includes one or more cross fluid treatment assemblies).
  • Fluid treatment assemblies (including feed and/or permeate channels) can be arranged in any flow configuration (serial flow and/or parallel flow) to provide a fluid path of desired length (e.g., 1-in-series, 2-in-series, etc.). In-line diafiltration is preferred.
  • Advantages include one or more of any of the following: a reduced footprint, a reduced number of moving parts, improved process integration including simplified operational requirements, reduced working volume, and reduced hold up volume.
  • a variety of desired removal efficiencies can be obtained, e.g., about 99% (2 log), about 99.9% (3 log) and about 99.99% (4 log), or even higher. However, for some applications, lower buffer efficiencies are suitable.
  • the feed fluid pump provides a controlled feed fluid flow rate through the feed fluid conduit to the fluid treatment assembly feed inlet at a flow rate that is lower than the simultaneously controlled diafiltration fluid flow rates through each of the separate diafiltration fluid conduits provided by the diafiltration pump (i.e., the diafiltration fluid rate rate through each channel is higher than the feed fluid flow rate).
  • the controlled diafiltration fluid flow rates through each of the separate diafiltration fluid conduits is at least about 13% higher, providing a 2 log removal efficiency; at least about 50% higher, providing a 3 log removal efficiency; and at least about 70% higher, providing a 4 log removal efficiency.
  • FIG. 1A shows an illustrative embodiment of a diafiltration system 1000 , comprising a diafiltration pump 200 including a driver 210 (preferably microprocessor controlled), multiple channel pump heads 215 ′ (including separate channels 215 and 215 a ), 215 ′′ (including separate channels 215 b and 215 c ), and 215 ′′′ (including separate channels 215 d and 215 e ) ( 215 ′ with separate channels 215 , 215 a , shown in more detail in FIG. 1B ), wherein the channels are suitable for receiving conduits such as diafiltration fluid conduits, wherein the system also includes a fluid treatment assembly 500 .
  • the diafiltration pump also includes a display 220 .
  • the illustrative fluid treatment assembly 500 shown in FIGS. 2A-2D, and 4A-4C comprises a bottom support plate 501 , a top support plate 502 , a bottom manifold plate 510 (e.g., a feed bottom manifold plate), and a top manifold plate 520 (e.g., a retentate/permeate top manifold plate), wherein the bottom and top manifold plates include one or more ports, such as a feed inlet 511 , a retentate outlet 521 , and a permeate outlet 522 .
  • a feed inlet 511 e.g., a feed bottom manifold plate
  • a top manifold plate 520 e.g., a retentate/permeate top manifold plate
  • the bottom and top manifold plates include one or more ports, such as a feed inlet 511 , a retentate outlet 521 , and a permeate outlet 522 .
  • the bottom manifold plate 510 comprises the feed inlet 511 (for introducing feed solution into the filter assembly), and the top manifold plate comprises the retentate outlet 521 (which allows buffer exchanged feed (e.g., protein) solution to pass to a collection vessel) and the permeate outlet 522 (which discharges exchange buffer).
  • the feed inlet 511 for introducing feed solution into the filter assembly
  • the top manifold plate comprises the retentate outlet 521 (which allows buffer exchanged feed (e.g., protein) solution to pass to a collection vessel) and the permeate outlet 522 (which discharges exchange buffer).
  • the fluid treatment assembly 500 includes two or more fluid treatment modules 530 , ( 530 a , 530 b , 530 c , 530 d , 530 e ). While a fluid treatment module can include a single cross flow treatment assembly, typically, and as illustrated in FIG.
  • an individual treatment module includes a plurality of cross flow treatment assemblies ( 550 , 550 ′, 550 a , 550 a ′, 550 b , 550 b ′, 550 c , 550 c ′, 550 d , 550 d ′, 550 e , 550 e ′), each including at least one ultrafiltration membrane (membranes are shown in FIG. 2B , illustrating membranes 560 , 560 ′, 560 ′′ and 560 ′′′ in a single cross flow treatment assembly), the cross flow treatment assembly having at least one feed side (sometimes referred to as a feed channel or feed layer) (illustratively shown in FIG.
  • FIG. 2B showing feed channels 561 , 561 ′), and at least one opposite permeate side (sometimes referred to as a permeate channel or permeate layer) (illustratively shown in FIG. 2B , showing permeate channels 562 , 562 ′, 562 ′′), and (as shown particularly in FIGS.
  • a diafiltration distribution plate 570 ( 570 a , 570 b , 570 c , 570 d , 570 e ) comprising a diafiltration fluid feed inlet 571 ( 571 a , 571 b, 571 c, 571 d, 571 e ), a diafiltration fluid feed channel 572 ( 572 a , 572 b, 572 c, 572 c, 572 e ) in fluid communication with the diafiltration fluid feed inlet 571 and a common feed/retentate port 600 ( 600 a , 600 b , 600 c , 600 d , 600 e ), and at least one (2 are illustrated in each plate) common feed permeate/diafiltration fluid permeate outlet port 700 ( 700 a , 700 b , 700 c , 700 d , 700 e ).
  • the diafiltration plate can include a common feed permeate/diafiltration fluid permeate outlet channel 744 ( 744 a, 744 b, 744 c, 744 d, 744 e ) and a common feed permeate/diafiltration fluid permeate aperture 745 ( 745 a , 745 b , 745 c , 745 d , 745 e ) in fluid communication with the common feed permeate/diafiltration fluid permeate outlet port.
  • some or all of the apertures are capped, preventing fluid flow therethrough (such that fluid flows through the common feed permeate/diafiltration fluid permeate outlet port 700 , but not the common feed permeate/diafiltration fluid permeate outlet channel 744 or the common feed permeate/diafiltration fluid permeate aperture 745 ).
  • FIGS. 3A and 3B also various configurations for the common feed/retentate port and the diafiltration fluid feed channel in the diafiltration plate, for introducing the diafiltration fluid into the feed/retentate port at different angles.
  • the “teardrop shaped” port 600 has 2 different inner diameters ( 601 having a larger opening coming to a point 603 at one surface of the plate, the opening being larger than the opening 602 in the round port below, such that there is a lip or shoulder 604 between the teardrop shape and the round aperture) may provide improved results, e.g., by providing a larger surface area for the mixing of feed and diafiltration (buffer) fluid streams.
  • the fluid treatment assembly includes at least one, more preferably, at least two, gaskets, wherein at least one gasket has 3 apertures and at least one gasket has 2 apertures.
  • FIG. 2A illustrates gasket 510 a between the first stage 530 and lower manifold plate 510 , gasket 520 b between sixth stage 530 e and the upper manifold plate 520 , and gasket 510 b between diafiltration plate 570 and cross treatment assembly 550 , wherein each gasket has 2 apertures
  • FIG. 2A illustrates gasket 510 a between the first stage 530 and lower manifold plate 510 , gasket 520 b between sixth stage 530 e and the upper manifold plate 520 , and gasket 510 b between diafiltration plate 570 and cross treatment assembly 550 , wherein each gasket has 2 apertures
  • FIG. 2A also illustrates gaskets 515 ( 515 ′, 515 a , 515 a ′, 515 a ′′, 515 b , 515 b ′, 515 b ′′, 515 c , 515 c ′, 515 c ′′, 515 d , 515 d ′, 515 d ′′, 515 e , 515 e ′) each having 3 apertures, on either side of the cross flow assemblies, with the exception of the first and last cross flow assemblies (wherein gaskets 510 b and 520 a are on one side of the cross flow treatment assemblies).
  • cross flow treatment assembly 530 is replaced by a second manifold plate 510 .
  • the illustrated system 1000 includes a plurality of separate diafiltration fluid feed conduits 590 ′ ( 590 , 590 a , 590 b , 590 c , 590 d , 590 e ), in fluid communication with a diafiltration fluid (e.g., buffer fluid) source 1570 , and diafiltration fluid feed inlets, wherein the diafiltration fluid feed conduits are separately arranged in the separate channels of the multiple channel pump head(s).
  • a diafiltration fluid e.g., buffer fluid
  • diafiltration fluid feed conduits are separately arranged in the separate channels of the multiple channel pump head(s). Accordingly, while individual diafiltration fluid feed conduit can be in fluid communication with a common diafiltration fluid source, an individual diafiltration fluid conduit only communicates with a single respective diafiltration feed fluid inlet of an individual cross flow treatment assembly, and the fluid flow rate through the individual conduit is controlled.
  • the fluid treatment assembly can be assembled as is known in the art. In the illustrated assembly shown in FIGS. 4A and 4B , the modules are stacked. If desired, the fluid treatment assemblies can include, for example, rods (e.g., compression and/or mounting rods), bolts, nuts, and washers, including, for example, as disclosed in U.S. Pat. No. 7,918,999, and U.S. Patent Application Publications 2008/0135499 and 2013/0118971.
  • rods e.g., compression and/or mounting rods
  • bolts e.g., nuts, and washers
  • the fluid treatment assemblies include threaded compression rods 1800 ( 1800 a , 1800 b , 1800 c ), threaded mounting rods 1800 ′, 1800 a ′ (wherein the mounting rods only pass through the support plates, and the compression rods pass through the support plates, the manifold plates and the diafiltration plates), washers 1801 ( 1801 a , 1801 b, 1801 c; 1801 ′, 1800 a ′) and threaded nuts 1802 ( 1802 a , 1802 b, 1802 c; 1802 ′, 1802 a ′), wherein the top and bottom support plates, the top and bottom manifold plates, and the diafiltration distribution plates, include holes allowing the rods to pass therethrough such that the modules can be stacked.
  • the mounting rods provide alignment support during stacking and assembling the modules, and the compression rods ensure application of a desired load and torque to functionalize the fluid treatment assembly.
  • the system 1000 further comprises a feed fluid pump 1500 , a feed fluid source 1510 , and at least one feed fluid conduit, 1511 , in fluid communication with the feed inlet 511 , at least one retentate conduit 1521 in fluid communication with the retentate outlet 521 and a collection container 1621 , at least one permeate conduit 1522 in fluid communication with the permeate outlet 522 and a permeate/waste container 1622 , typically, wherein the permeate conduit 1522 is also in fluid communication with one or more common feed permeate/diafiltration fluid permeate outlet ports (e.g., FIG. 2D shows permeate passing through each of the common permeate ports ( 700 , 700 a , 700 b , 700 c , 700 d , 700 e ) through permeate outlet 522 to permeate conduit 1522 ).
  • FIG. 2D shows permeate passing through each of the common permeate ports ( 700 , 700 a , 700 b , 700 c
  • the system can include one or more diafiltration fluid permeate conduits in fluid communication with the common feed permeate/diafiltration fluid permeate outlet channels 744 ( 744 , 744 a, 744 b ) and the common feed permeate/diafiltration fluid permeate apertures ( 745 , 745 a , 745 b (the apertures shown as capped in FIG. 2D )) and the permeate/waste container 1622 and/or a diafiltration permeate container (conduits and diafiltration permeate container not shown).
  • the system can also include, for example, one or more monitoring devices for monitoring one or more of any of the following: pressure (e.g., inlet pressure, outlet pressure and/or backpressure), flow rates, and conductivity, and/or one or more valves, e.g., retentate and/or permeate throttling valves (sometimes referred to as control valves), for example, for adjusting one or more of any of the following: flow ratio between feed and retentate, and/or adjusting backpressure.
  • pressure e.g., inlet pressure, outlet pressure and/or backpressure
  • valves e.g., retentate and/or permeate throttling valves (sometimes referred to as control valves)
  • retentate and/or permeate throttling valves sometimes referred to as control valves
  • Suitable flow meters, pressure sensors, conductivity sensors, and throttle valves are known in the art.
  • the system comprises flow meters and pressure sensors associated with each inlet fluid flow path communicating with the fluid treatment assembly, and with the retentate fluid path path exiting the fluid treatment assembly, and conductivity sensors and throttle valves associated with the retentate and permeate fluid flow paths exiting the fluid treatment assembly.
  • a flow meter and a pressure sensor are associated with the feed fluid inlet fluid flow path
  • a flow meter and a pressure sensor is associated with the retentate fluid flow path.
  • the embodiment of the system illustrated in FIG. 1C comprises a flow meter 800 ′ and 900 ′ associated with feed conduit 1511 , as well as flow meters 800 ( 800 a , 800 b , 800 c , 800 d , 800 e ) and pressure sensors 900 ( 900 a , 900 b , 900 c , 900 d , 900 e ) associated with the respective diafiltration feed fluid conduits 590 ( 590 , 590 a , 590 b , 590 c , 590 d , 590 e ), also comprising flow meter 821 and pressure sensor 921 associated with retentate conduit 1521 , as well as conductivity sensor 1021 and throttle valve 1121 associated with retentate conduit 1521 , and conductivity sensor 1022 and throttle valve 1122 associated with permeate conduit 1522 .
  • the throttle valve 1122 is replaced with a flow meter, and the
  • a variety of diafiltration fluid and feed fluid pumps preferably microprocessor controlled drive pumps
  • multiple channel (e.g., 2, 4, 8, 12, 16, and 24 channel, or more channels) pump heads are suitable for use in the invention, and suitable pumps and pump heads are commercially available (e.g., from Cole-Palmer Instrument Company (Vernon Hills, Ill.), under the names MASTERFLEX, and ISMATEC, among others).
  • the pumps have multiple rollers, e.g., 2, 3, 4, or more rollers).
  • the diafiltration pump (and for some applications, the feed pump) provides a calibrated flow rate, and, if desired, a calibrated dispensing volume.
  • the multiple channel pump head is integral with the pump.
  • a multiple channel head can be used, along with additional pump heads that can be multiple channel and/or single channel.
  • Embodiments of the invention can utilize a variety of tubing sizes and/or tubing materials, and suitable sizes and materials are known to one of skill in the art.
  • the diafiltration distribution plate can be formed of various materials known in the art, including, for example, polymeric materials such as polypropylene.
  • feed channels and permeate channels are suitable for use in the invention.
  • the feed channels and permeate channels include spacer materials and/or perforate materials such as screens or meshes.
  • the screens or meshes can have any suitable size openings, e.g., fine, medium, or coarse size openings.
  • a cross fluid treatment assembly can have any number of membranes, feed channels, and permeate channels, including, for example, those disclosed in U.S. Pat. No. 8,980,088.
  • FIG. 2B illustrates an exemplary cross fluid treatment assembly 550 comprising 4 UF membranes ( 560 , 560 ′, 560 ′′, 560 ′′), wherein each membrane is arranged between a permeate channel ( 562 , 562 ′, 562 ′′) and a feed channel ( 561 , 561 ′).
  • cross fluid treatment assembly components can be combined to provide cross fluid treatment sub-assemblies, e.g., wherein a permeate channel and a membrane are combined to form a permeate channel/membrane sub-assembly.
  • FIG. 2C shows top, middle, and bottom permeate channel/membrane sub-assemblies 550 - 1 , 550 - 2 , and 550 - 3 , respectively, and a feed channel is arranged between the top and middle sub-assembly, and another feed channel is arranged between the middle sub-assembly and the bottom sub-assembly.
  • FIG. 2C shows top, middle, and bottom permeate channel/membrane sub-assemblies 550 - 1 , 550 - 2 , and 550 - 3 , respectively, and a feed channel is arranged between the top and middle sub-assembly, and another feed channel is arranged between the middle sub-assembl
  • FIG. 2C shows various seals associated with various cross fluid treatment components, illustrated as feed channel seals 561 a ′, 561 a ′′, 561 ′ a ′, 561 ′ a ′′, and permeate channel seals 562 a ′, 562 a ′′.
  • the UF membrane can be formed from any of numerous materials, including those known in the art, including, for example, a natural or synthetic polymer, including, e.g., regenerated cellulose, polyethersulfone, etc.
  • the membrane can be supported or unsupported.
  • the membrane can have any suitable pore structure, e.g., a wide range of molecular cutoffs (such as, e.g., 10 kDa, 30 kDa, etc.) or removal ratings. Suitable membranes include those known in the art.
  • the membrane may have, or may be modified to have, any of a myriad of fluid treatment characteristics.
  • the membrane may have a positive, negative, or neutral electrical charge; it may be liquiphobic or liquiphilic, including hydrophobic or hydrophilic or oleophobic or oleophilic; and/or it may have attached functional groups, such as ligands or any other reactive moiety, that can chemically bind to substances in the fluid.
  • the membrane may be formed from, impregnated with, or otherwise contain a variety of materials that function to further treat the fluid in any of numerous ways.
  • These functional materials may include, for example, sorbents, ion exchange resins, chromatography media, enzymes, reactants, or catalysts of all types that may chemically and/or physically bind, react with, catalyze, deliver, or otherwise affect substances in the fluid or the fluid itself
  • the membrane can have any desired critical wetting surface tension (CWST, as defined in, for example, U.S. Pat. No. 4,925,572).
  • CWST can be selected as is known in the art, e.g., as additionally disclosed in, for example, U.S. Pat. Nos. 5,152,905, 5,443,743, 5,472,621, and 6,074,869.
  • FIGS. 2D and 4C show fluid flow pathways through the assemblies when operated in a co-current manner
  • FIGS. 2D and 4C show fluid flow pathways through the assemblies when operated in a co-current manner
  • a diafiltration system is set up including a fluid treatment assembly as generally shown in FIG. 4 (A and B), wherein the diafiltration pump and diafiltration system are arranged as generally shown in FIGS. 1A and 1C , including a MASTERFLEX L/S Precision Variable Speed Pump Drive (Model No: EW-07528-30), with three MASTERFLEX L/S Multi-channel Pump Heads (Model No: 07536-002) and MASTERFLEX L/S High Performance Precision 2-stop tubing sets (L/S 15, 06421-15) (Cole-Palmer Instrument Company, Vernon Hills, Ill.).
  • MASTERFLEX L/S Precision Variable Speed Pump Drive Model No: EW-07528-30
  • MASTERFLEX L/S Multi-channel Pump Heads Model No: 07536-002
  • MASTERFLEX L/S High Performance Precision 2-stop tubing sets L/S 15, 06421-15
  • the fluid treatment assembly has 6 stages, each stage having 2-in-series cross fluid treatment assemblies, each cross fluid treatment assembly including Delta regenerated cellulose UF membranes, each with a 30 kDa cutoff and a surface area of 186 cm 2 (total membrane area for the fluid treatment assembly is 2232 cm 2 ).
  • the feed solution is 10 g/L polyclonal bovine IgG in 0.025 M sodium acetate plus 0.5 M sodium chloride (NaCl) (conductivity 47 mS/cm).
  • the diafiltration (DF) solution (buffer solution) is 0.025 M sodium acetate plus 0.05 M NaCl (conductivity 6.7 mS/cm).
  • the diafiltration fluid flow rate in each channel is about 11.7 mL/min, and when the feed fluid flow rate is 20 mL/min, the diafiltration fluid flow rate in each channel is about 23.3 mL/min.
  • the flow rate distribution per DF stage remains generally uniform around 10 mL/min.
  • the distribution of pressures remain generally uniform around 12 psig for DF stages 1-3, decreasing toward the retentate outlet from about 9 psig to about 4 psig for DF stages 4-6.
  • the flow rate distribution per DF stage remains generally uniform around 18-20 mL/min.
  • the distribution of pressures remain generally uniform around 28 psig for DF stages 1-3, decreasing toward the retentate outlet from about 25 psig to about 9 psig for DF stages 4-6.
  • the diafiltration system, fluid treatment assembly, and feed and DF solutions are as described in Example 1.
  • the diafiltration fluid flow rate in each channel is about 10.8 mL/min, and when the feed fluid flow rate is 10 mL/min, the diafiltration fluid flow rate in each channel is about 22.7 mL/min.
  • the flow rate distribution per DF stage remains generally uniform around 10 mL/min for DF stages 1-6.
  • the pressures at DF stages 1 and 2 are 15 psig and 17 psig, respectively, the distribution of pressures remain generally uniform around 20 psig for DF stages 3-5, and decrease to about 15 psig for DF stage 6.
  • the flow rate distribution per DF stage is in the range of around 11-9 mL/min for DF stages 2-4, and around 7 psig for DF stages 5 and 6.
  • the distribution of pressures ranges from around 34 psig for DF stage 1, decreasing about 1 to 2 psig per stage toward the retentate outlet to about 25 psig for DF stage 6.
  • both the pressure and flow rate management is relatively easy and uniform for targeting the 99.9% removal efficiency.
  • the diafiltration system, fluid treatment assembly, and feed and DF solutions are as described in Example 1.
  • the flow rate distribution per DF stage remains in the range of around 8-12 mL/min for DF stages 1-6.
  • the distribution of pressures ranges from around 34 psig for DF stage 1, decreasing about 1 to 2 psig per stage toward the retentate outlet to about 26 psig for DF stage 6.
  • a diafiltration system is set up including a fluid treatment assembly as generally described in Example 1.
  • the fluid treatment assembly has 6 stages, each stage having 3-in-series cross fluid treatment assemblies, each cross fluid treatment assembly including Delta regenerated cellulose UF membranes, each with a 30 kDa cutoff and a surface area of 186 cm 2 .
  • the feed solution is 60 g/L polyclonal bovine IgG in 0.025 M sodium acetate plus 0.5 M sodium chloride (NaCl) (conductivity 47 mS/cm).
  • the diafiltration (DF) solution (buffer solution) is 0.025 M sodium acetate plus 0.05 M NaCl (conductivity 6.7 mS/cm).
  • the diafiltration fluid flow rate in each channel is about 11.7 mL/min, and when the feed fluid flow rate is 6 mL/min, the diafiltration fluid flow rate in each channel is about 13 mL/min.
  • the flow rate at DF stage 1 is about 6 mL/min
  • at DF stage 2 is about 7 mL/min, remaining uniform at about 10 mL/min for DF stages 3-6.
  • the pressures at DF stages 1-6 are 33 psig, 31 psig, 28 psig, 16 psig, 11 psig, and 8 psig, respectively.
  • the flow rate at DF stage 1 is 4 mL/min
  • at DF stage 2 is about 8 mL/min, remaining uniform at about 10 mL/min for DF stages 3-5, and about 12 mL/min for DF stage 6.
  • the pressures at DF stages 1-6 are 29 psig, 28 psig, 24 psig, 15 psig, 10 psig, and 8 psig, respectively.
  • This example illustrates testing utilizing diafiltration markers for better quantification of target percent removal efficiencies.
  • the fluid treatment assembly is as described in Example 4.
  • the feed solution is 60 g/L polyclonal bovine IgG with glucose as a representative small molecule.
  • the feed solution is 60 g/L IgG in 0.025 M Na Acetate plus 0.05 M NaCl plus 50 g/L glucose (conductivity 6.7 mS/cm).
  • the DF solution buffer solution is 0.025 M Na Acetate plus 0.05 M NaCl (conductivity 6.7 mS/cm).
  • the detection limit of the glucose is 0.03 g/L.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Water Supply & Treatment (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nanotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Immunology (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

A diafiltration system comprises a fluid treatment assembly comprising two or more fluid treatment modules, the fluid treatment assembly comprising a feed inlet, a permeate outlet, and a retentate outlet; each module comprising a cross flow treatment assembly including an ultrafiltration membrane and having a feed side and a permeate side, and a diafiltration fluid distribution plate comprising a diafiltration fluid feed inlet and a common feed permeate/diafiltration fluid permeate outlet port; two or more diafiltration fluid conduits, each conduit in fluid communication with a respective single diafiltration fluid feed inlet; and, a diafiltration fluid pump comprising at least a first multiple channel pump head having at least two channels including separate channels for separate conduits in fluid communication with respective single diafiltration fluid feed inlets, wherein the pump provides simultaneously controlled diafiltration fluid flow rates through each of the conduits to the respective diafiltration fluid feed inlets.

Description

    BACKGROUND OF THE INVENTION
  • Diafiltration is a technique that uses ultrafiltration (UF) membranes to remove, replace, or lower the concentration of undesirable materials such as salts and/or solvents from fluids containing desirable materials, for example, desired biomolecules such as proteins, peptides, and nucleic acids. A UF membrane retains molecules that are larger than the pores of the membrane (the solution containing the retained molecules is referred to as the retentate or concentrate), and smaller molecules such as salts, solvents, and water (which are 100% permeable), freely pass through the membrane (providing a solution referred to as the permeate or filtrate).
  • Continuous diafiltration (sometimes referred to as constant volume diafiltration) involves washing out the original buffer salts (and/or other low molecular weight species) in the retentate by adding water or new buffer to the retentate at the same rate as filtrate is being generated. As a result, the retentate volume and product concentration does not change during the diafiltration process. If water is used for diafiltering, the salts will be washed out and the conductivity lowered. If a buffer is used for diafiltering, the new buffer salt concentration will increase at a rate inversely proportional to that of the species being removed, and the conductivity will be increased. The amount of salt removed is related to the filtrate volume generated, relative to the retentate volume. The filtrate volume generated is usually referred to in terms of “diafiltration volumes.” A single diafiltration volume (DV) is the volume of retentate when diafiltration is started. For continuous diafiltration, liquid is added at the same rate as filtrate is generated. When the volume of filtrate collected equals the starting retentate volume, 1 DV has been processed. Using continuous diafiltration, greater than 99.5% of a 100% permeable solute can be removed by washing through 6 retentate volumes (6DV) with the buffer of choice.
  • However, there is a need for improved diafiltration systems and methods.
  • The present invention provides for ameliorating at least some of the disadvantages of the prior art. These and other advantages of the present invention will be apparent from the description as set forth below.
  • BRIEF SUMMARY OF THE INVENTION
  • An embodiment of the invention provides a diafiltration system comprising (a) a fluid treatment assembly comprising two or more fluid treatment modules, the fluid treatment assembly comprising a feed inlet, and permeate outlet, and a retentate outlet; (i) each fluid treatment module comprising a cross flow treatment assembly including at least one ultrafiltration membrane, the fluid treatment assembly comprising having at least one feed side and at least one opposite permeate side, and a diafiltration fluid distribution plate comprising a diafiltration fluid feed inlet and a common feed permeate/diafiltration fluid permeate outlet port; (b) two or more separate diafiltration fluid conduits, each separate diafiltration fluid conduit in fluid communication with a respective single diafiltration fluid feed inlet; and, (c) a diafiltration fluid pump, the diafiltration fluid pump comprising at least a first multiple channel pump head having at least two channels including separate channels for separate diafiltration fluid conduits in fluid communication with respective single diafiltration fluid feed inlets, wherein the diafiltration pump provides simultaneously controlled diafiltration fluid flow rates through each of the separate diafiltration fluid conduits to the respective single diafiltration fluid feed inlets.
  • In another embodiment, a method of diafiltration is provided, the method comprising passing a feed fluid containing undesirable material and desirable biomolecules, and a diafiltration fluid suitable for washing out undesirable material from the feed fluid, through the fluid treatment assembly in an embodiment of the diafiltration system, wherein the method includes (a) passing the feed fluid at a controlled feed fluid flow rate through the feed inlet of the fluid treatment assembly; (b) passing the diafiltration fluid at a controlled diafiltration fluid flow rate through each of the separate diafiltration fluid conduits in fluid communication with respective single diafiltration fluid feed inlets, such that the diafiltration fluid washes undesirable material from the feed fluid, wherein the controlled diafiltration fluid flow rate is simultaneously controlled through each of the separate diafiltration fluid conduits; (c) passing a feed permeate/diafiltration fluid permeate fluid through each of the common feed permeate/diafiltration fluid permeate outlet ports; (d) passing a retentate fluid from the retentate outlet of fluid treatment assembly, the retentate fluid comprising desirable biomolecules and a lower concentration of undesirable material than the concentration of undesirable material in the feed fluid; and (e) passing the feed permeate/diafiltration fluid permeate fluid from the permeate outlet of the fluid treatment assembly.
  • BRIEF DESCRIPTION OF THE SEVERAL VIEWS OF THE DRAWING(S)
  • FIG. 1A is a diagrammatic view of a diafiltration pump including a plurality of multiple channel pump heads for use in an embodiment of the invention. FIG. 1B is a diagrammatic view of an open multiple channel pump head, illustrating separate channels.
  • FIG. 1C is a schematic view of an embodiment of a diafiltration system according to the present invention, wherein the illustrated diafiltration system comprises a fluid treatment assembly including a plurality of fluid treatment modules, a plurality of diafiltration fluid conduits, and a diafiltration pump including a plurality of multiple channel pump heads.
  • FIG. 2A is an exploded view of an illustrative fluid treatment assembly including a plurality of fluid treatment modules, the fluid treatment modules including cross flow treatment assemblies.
  • FIGS. 2B and 2C show exploded views of a cross flow treatment assembly in a fluid treatment module shown in FIG. 2A. FIG. 2B shows individual components, and FIG. 2C shows some of the components combined to show sub-assemblies.
  • FIG. 2D shows fluid flow pathways through the fluid treatment assembly shown in FIG. 2A.
  • FIG. 3A and FIG. 3B show top perspective views of exemplary diafiltration fluid distribution plates for use in fluid treatment modules, the plates each including a diafiltration fluid feed inlet, a diafiltration fluid inlet port, a diafiltration fluid feed channel, a diafiltration fluid permeate port, and a diafiltration fluid permeate outlet
  • FIG. 4A is a front view of 2 assembled fluid treatment assemblies including 6 fluid treatment modules, one set of modules including 2 in-series cross flow treatment assemblies, the other set of modules including 3 in-series cross flow treatment assemblies; FIG. 4B is a rear view of the assembled fluid treatment assemblies shown in FIG. 4A, and FIG. 4C shows fluid flow pathways through the fluid treatment assembly including 2 in-series cross flow treatment assemblies shown in FIG. 4A.
  • DETAILED DESCRIPTION OF THE INVENTION
  • In accordance with an embodiment of the present invention, a diafiltration system is provided, the system comprising (a) a fluid treatment assembly comprising two or more fluid treatment modules, the fluid treatment assembly comprising a feed inlet, and permeate outlet, and a retentate outlet; (i) each fluid treatment module comprising a cross flow treatment assembly including at least one ultrafiltration membrane, the cross flow treatment assembly having at least one feed side and at least one opposite permeate side, and a diafiltration fluid distribution plate comprising a diafiltration fluid feed inlet and a common feed permeate/diafiltration fluid permeate outlet port; (b) two or more separate diafiltration fluid conduits, each separate diafiltration fluid conduit in fluid communication with a respective single diafiltration fluid feed inlet; and, (c) a diafiltration fluid pump, the diafiltration fluid pump comprising at least a first multiple channel pump head having at least two channels including separate channels for separate diafiltration fluid conduits in fluid communication with respective single diafiltration fluid feed inlets, wherein the diafiltration pump provides simultaneously controlled diafiltration fluid flow rates through each of the separate diafiltration fluid conduits to the respective single diafiltration fluid feed inlets.
  • In another embodiment, a diafiltration fluid distribution plate is provided, the plate comprising a diafiltration fluid feed inlet and the diafiltration fluid feed channel communicating with the diafiltration fluid feed inlet, and a common feed retentate port, wherein the common feed retentate port has 2 different inner diameters.
  • Typically, the diafiltration system further comprises a feed fluid pump and a feed fluid conduit, wherein the feed fluid conduit is in fluid communication with the fluid treatment assembly feed inlet, wherein the feed fluid pump provides a controlled feed fluid flow rate through the feed fluid conduit to the fluid treatment assembly feed inlet.
  • In an embodiment, the diafiltration system includes at least one additional channel pump head having including a separate channel for a separate diafiltration fluid conduit in fluid communication with a single diafiltration fluid feed inlet, wherein the pump, via the first multiple channel pump head and the additional channel pump head, provides simultaneously controlled diafiltration fluid flow rates through each of the separate diafiltration fluid conduits to the respective single diafiltration fluid feed inlets.
  • Alternatively, or additionally, an embodiment of the diafiltration system of claim includes at least one additional multiple channel pump head having at least two channels including a separate channel for a separate diafiltration fluid conduit in fluid communication with a single diafiltration fluid feed inlet, wherein the pump, via the first multiple channel pump head and the additional multiple channel pump head, provides simultaneously controlled diafiltration fluid flow rates through each of the separate diafiltration fluid conduits to the respective single diafiltration fluid feed inlets.
  • In some embodiments, the diafiltration system further comprises a retentate throttling valve, arranged to allow the system to maintain a desired ratio of feed flow rate to retentate flow rate.
  • In another embodiment, a method of diafiltration is provided, the method comprising passing a feed fluid containing undesirable material and desirable biomolecules, and a diafiltration fluid suitable for washing out undesirable material from the feed fluid, through the fluid treatment assembly in an embodiment of the diafiltration system, wherein the method includes (a) passing the feed fluid at a controlled feed fluid flow rate through the feed inlet of the fluid treatment assembly; (b) passing the diafiltration fluid at a controlled diafiltration fluid flow rate through each of the separate diafiltration fluid conduits in fluid communication with respective single diafiltration fluid feed inlets, such that the diafiltration fluid washes undesirable material from the feed fluid, wherein the controlled diafiltration fluid flow rate is simultaneously controlled through each of the separate diafiltration fluid conduits; (c) passing a feed permeate/diafiltration fluid permeate fluid through each of the common feed permeate/diafiltration fluid permeate outlet ports; (d) passing a retentate fluid from the retentate outlet of fluid treatment assembly, the retentate fluid comprising desirable biomolecules and a lower concentration of undesirable material than the concentration of undesirable material in the feed fluid; and (e) passing the feed permeate/diafiltration fluid permeate fluid from the permeate outlet of the fluid treatment assembly.
  • Typically, e.g., for some applications wherein at least 2 log (99%) removal efficiencies are desirable, the feed fluid pump provides a controlled feed fluid flow rate through the feed fluid conduit to the fluid treatment assembly feed inlet at a flow rate that is lower than (e.g., at least about 10% lower than) the simultaneously controlled diafiltration fluid flow rates through each of the separate diafiltration fluid conduits provided by the diafiltration pump.
  • The invention is suitable for discontinuous diafiltration (including sequential dilution and volume reduction), and, more preferably, continuous diafiltration, wherein the diafiltration fluid flow rate is managed through a single point of control. Additionally, while “continuous diafiltration” as conventionally carried out involves the continuous addition of buffer to into the product tank, and the product of interest (e.g., desirable proteins) is recirculated within the system, embodiments of the invention can encompass “continuous diafiltration in its entirety,” such that the product of interest is not recirculated within the system; rather, it is processed continuously in a single-pass mode of operation.
  • Fluids can be passed through the fluid treatment assembly in co-current and counter-current flow directions, in a single-pass mode or a continuous-pass mode.
  • Fluid treatment assemblies can include any number of fluid treatment modules (e.g., “stages,” such as 2, 3, 4, 5, 6, 7, or more, stages), wherein an individual module (stage) includes one or more cross fluid treatment assemblies). Fluid treatment assemblies (including feed and/or permeate channels) can be arranged in any flow configuration (serial flow and/or parallel flow) to provide a fluid path of desired length (e.g., 1-in-series, 2-in-series, etc.). In-line diafiltration is preferred.
  • Advantages include one or more of any of the following: a reduced footprint, a reduced number of moving parts, improved process integration including simplified operational requirements, reduced working volume, and reduced hold up volume.
  • A variety of desired removal efficiencies can be obtained, e.g., about 99% (2 log), about 99.9% (3 log) and about 99.99% (4 log), or even higher. However, for some applications, lower buffer efficiencies are suitable.
  • As noted above, typically, the feed fluid pump provides a controlled feed fluid flow rate through the feed fluid conduit to the fluid treatment assembly feed inlet at a flow rate that is lower than the simultaneously controlled diafiltration fluid flow rates through each of the separate diafiltration fluid conduits provided by the diafiltration pump (i.e., the diafiltration fluid rate rate through each channel is higher than the feed fluid flow rate). Illustratively, in one embodiment of the system comprising a fluid treatment assembly including 6 stages, operated co-currently, the controlled diafiltration fluid flow rates through each of the separate diafiltration fluid conduits is at least about 13% higher, providing a 2 log removal efficiency; at least about 50% higher, providing a 3 log removal efficiency; and at least about 70% higher, providing a 4 log removal efficiency.
  • Each of the components of the invention will now be described in more detail below, wherein like components have like reference numbers.
  • FIG. 1A shows an illustrative embodiment of a diafiltration system 1000, comprising a diafiltration pump 200 including a driver 210 (preferably microprocessor controlled), multiple channel pump heads 215′ (including separate channels 215 and 215 a), 215″ (including separate channels 215 b and 215 c), and 215′″ (including separate channels 215 d and 215 e) (215′ with separate channels 215, 215 a, shown in more detail in FIG. 1B), wherein the channels are suitable for receiving conduits such as diafiltration fluid conduits, wherein the system also includes a fluid treatment assembly 500. Typically, the diafiltration pump also includes a display 220.
  • The illustrative fluid treatment assembly 500 shown in FIGS. 2A-2D, and 4A-4C comprises a bottom support plate 501, a top support plate 502, a bottom manifold plate 510 (e.g., a feed bottom manifold plate), and a top manifold plate 520 (e.g., a retentate/permeate top manifold plate), wherein the bottom and top manifold plates include one or more ports, such as a feed inlet 511, a retentate outlet 521, and a permeate outlet 522. In the fluid treatment assembly 500 shown in FIGS. 4A and 4B, the bottom manifold plate 510 comprises the feed inlet 511 (for introducing feed solution into the filter assembly), and the top manifold plate comprises the retentate outlet 521 (which allows buffer exchanged feed (e.g., protein) solution to pass to a collection vessel) and the permeate outlet 522 (which discharges exchange buffer).
  • As shown in, for example, FIG. 2A, the fluid treatment assembly 500 includes two or more fluid treatment modules 530, (530 a, 530 b, 530 c, 530 d, 530 e). While a fluid treatment module can include a single cross flow treatment assembly, typically, and as illustrated in FIG. 2A for example, an individual treatment module includes a plurality of cross flow treatment assemblies (550, 550′, 550 a, 550 a′, 550 b, 550 b′, 550 c, 550 c′, 550 d, 550 d′, 550 e, 550 e′), each including at least one ultrafiltration membrane (membranes are shown in FIG. 2B, illustrating membranes 560, 560′, 560″ and 560′″ in a single cross flow treatment assembly), the cross flow treatment assembly having at least one feed side (sometimes referred to as a feed channel or feed layer) (illustratively shown in FIG. 2B, showing feed channels 561, 561′), and at least one opposite permeate side (sometimes referred to as a permeate channel or permeate layer) (illustratively shown in FIG. 2B, showing permeate channels 562, 562′, 562″), and (as shown particularly in FIGS. 3A and 3B) a diafiltration distribution plate 570 (570 a, 570 b, 570 c, 570 d, 570 e) comprising a diafiltration fluid feed inlet 571 (571 a, 571 b, 571 c, 571 d, 571 e), a diafiltration fluid feed channel 572 (572 a, 572 b, 572 c, 572 c, 572 e) in fluid communication with the diafiltration fluid feed inlet 571 and a common feed/retentate port 600 (600 a, 600 b, 600 c, 600 d, 600 e), and at least one (2 are illustrated in each plate) common feed permeate/diafiltration fluid permeate outlet port 700 (700 a, 700 b, 700 c, 700 d, 700 e).
  • If desired, the diafiltration plate can include a common feed permeate/diafiltration fluid permeate outlet channel 744 (744 a, 744 b, 744 c, 744 d, 744 e) and a common feed permeate/diafiltration fluid permeate aperture 745 (745 a, 745 b, 745 c, 745 d, 745 e) in fluid communication with the common feed permeate/diafiltration fluid permeate outlet port. In some applications, some or all of the apertures are capped, preventing fluid flow therethrough (such that fluid flows through the common feed permeate/diafiltration fluid permeate outlet port 700, but not the common feed permeate/diafiltration fluid permeate outlet channel 744 or the common feed permeate/diafiltration fluid permeate aperture 745).
  • FIGS. 3A and 3B also various configurations for the common feed/retentate port and the diafiltration fluid feed channel in the diafiltration plate, for introducing the diafiltration fluid into the feed/retentate port at different angles. In one embodiment, the “teardrop shaped” port 600 has 2 different inner diameters (601 having a larger opening coming to a point 603 at one surface of the plate, the opening being larger than the opening 602 in the round port below, such that there is a lip or shoulder 604 between the teardrop shape and the round aperture) may provide improved results, e.g., by providing a larger surface area for the mixing of feed and diafiltration (buffer) fluid streams.
  • Typically, the fluid treatment assembly includes at least one, more preferably, at least two, gaskets, wherein at least one gasket has 3 apertures and at least one gasket has 2 apertures. For example, FIG. 2A illustrates gasket 510 a between the first stage 530 and lower manifold plate 510, gasket 520 b between sixth stage 530 e and the upper manifold plate 520, and gasket 510 b between diafiltration plate 570 and cross treatment assembly 550, wherein each gasket has 2 apertures, and FIG. 2A also illustrates gaskets 515 (515′, 515 a, 515 a′, 515 a″, 515 b, 515 b′, 515 b″, 515 c, 515 c′, 515 c″, 515 d, 515 d′, 515 d″, 515 e, 515 e′) each having 3 apertures, on either side of the cross flow assemblies, with the exception of the first and last cross flow assemblies (wherein gaskets 510 b and 520 a are on one side of the cross flow treatment assemblies). In a (non-illustrated) variation of the embodiment shown in FIG. 2A, cross flow treatment assembly 530 is replaced by a second manifold plate 510.
  • The illustrated system 1000 includes a plurality of separate diafiltration fluid feed conduits 590′ (590, 590 a, 590 b, 590 c, 590 d, 590 e), in fluid communication with a diafiltration fluid (e.g., buffer fluid) source 1570, and diafiltration fluid feed inlets, wherein the diafiltration fluid feed conduits are separately arranged in the separate channels of the multiple channel pump head(s). Accordingly, while individual diafiltration fluid feed conduit can be in fluid communication with a common diafiltration fluid source, an individual diafiltration fluid conduit only communicates with a single respective diafiltration feed fluid inlet of an individual cross flow treatment assembly, and the fluid flow rate through the individual conduit is controlled.
  • The fluid treatment assembly can be assembled as is known in the art. In the illustrated assembly shown in FIGS. 4A and 4B, the modules are stacked. If desired, the fluid treatment assemblies can include, for example, rods (e.g., compression and/or mounting rods), bolts, nuts, and washers, including, for example, as disclosed in U.S. Pat. No. 7,918,999, and U.S. Patent Application Publications 2008/0135499 and 2013/0118971. In the illustrated embodiments, the fluid treatment assemblies include threaded compression rods 1800 (1800 a, 1800 b, 1800 c), threaded mounting rods 1800′, 1800 a′ (wherein the mounting rods only pass through the support plates, and the compression rods pass through the support plates, the manifold plates and the diafiltration plates), washers 1801 (1801 a, 1801 b, 1801 c; 1801′, 1800 a′) and threaded nuts 1802 (1802 a, 1802 b, 1802 c; 1802′, 1802 a′), wherein the top and bottom support plates, the top and bottom manifold plates, and the diafiltration distribution plates, include holes allowing the rods to pass therethrough such that the modules can be stacked. Typically, the mounting rods provide alignment support during stacking and assembling the modules, and the compression rods ensure application of a desired load and torque to functionalize the fluid treatment assembly.
  • Other assembly configurations are known in the art, e.g., including bands or holderless configurations, for example, as disclosed in U.S. Patent Application Publication 2013/0118971.
  • Typically, the system 1000 further comprises a feed fluid pump 1500, a feed fluid source 1510, and at least one feed fluid conduit, 1511, in fluid communication with the feed inlet 511, at least one retentate conduit 1521 in fluid communication with the retentate outlet 521 and a collection container 1621, at least one permeate conduit 1522 in fluid communication with the permeate outlet 522 and a permeate/waste container 1622, typically, wherein the permeate conduit 1522 is also in fluid communication with one or more common feed permeate/diafiltration fluid permeate outlet ports (e.g., FIG. 2D shows permeate passing through each of the common permeate ports (700, 700 a, 700 b, 700 c, 700 d, 700 e) through permeate outlet 522 to permeate conduit 1522).
  • Additionally, or alternatively, if desired (e.g., for some applications involving counter-current operation), the system can include one or more diafiltration fluid permeate conduits in fluid communication with the common feed permeate/diafiltration fluid permeate outlet channels 744 (744, 744 a, 744 b) and the common feed permeate/diafiltration fluid permeate apertures (745, 745 a, 745 b (the apertures shown as capped in FIG. 2D)) and the permeate/waste container 1622 and/or a diafiltration permeate container (conduits and diafiltration permeate container not shown).
  • The system can also include, for example, one or more monitoring devices for monitoring one or more of any of the following: pressure (e.g., inlet pressure, outlet pressure and/or backpressure), flow rates, and conductivity, and/or one or more valves, e.g., retentate and/or permeate throttling valves (sometimes referred to as control valves), for example, for adjusting one or more of any of the following: flow ratio between feed and retentate, and/or adjusting backpressure. Suitable flow meters, pressure sensors, conductivity sensors, and throttle valves are known in the art.
  • In some embodiments, the system comprises flow meters and pressure sensors associated with each inlet fluid flow path communicating with the fluid treatment assembly, and with the retentate fluid path path exiting the fluid treatment assembly, and conductivity sensors and throttle valves associated with the retentate and permeate fluid flow paths exiting the fluid treatment assembly. Typically, a flow meter and a pressure sensor are associated with the feed fluid inlet fluid flow path, and a flow meter and a pressure sensor is associated with the retentate fluid flow path.
  • For example, the embodiment of the system illustrated in FIG. 1C comprises a flow meter 800′ and 900′ associated with feed conduit 1511, as well as flow meters 800 (800 a, 800 b, 800 c, 800 d, 800 e) and pressure sensors 900 (900 a, 900 b, 900 c, 900 d, 900 e) associated with the respective diafiltration feed fluid conduits 590 (590, 590 a, 590 b, 590 c, 590 d, 590 e), also comprising flow meter 821 and pressure sensor 921 associated with retentate conduit 1521, as well as conductivity sensor 1021 and throttle valve 1121 associated with retentate conduit 1521, and conductivity sensor 1022 and throttle valve 1122 associated with permeate conduit 1522. In a variation of the system of the system illustrated in FIG. 1C, the throttle valve 1122 is replaced with a flow meter, and the system does not include flow meters and pressure sensors associated with the respective diafiltration feed fluid conduits.
  • A variety of diafiltration fluid and feed fluid pumps (preferably microprocessor controlled drive pumps) and multiple channel (e.g., 2, 4, 8, 12, 16, and 24 channel, or more channels) pump heads (including, but not limited to stackable pump heads and cartridge pump heads) are suitable for use in the invention, and suitable pumps and pump heads are commercially available (e.g., from Cole-Palmer Instrument Company (Vernon Hills, Ill.), under the names MASTERFLEX, and ISMATEC, among others). Typically, the pumps have multiple rollers, e.g., 2, 3, 4, or more rollers). Preferably, the diafiltration pump (and for some applications, the feed pump) provides a calibrated flow rate, and, if desired, a calibrated dispensing volume. In some embodiments, the multiple channel pump head is integral with the pump. In some embodiments having a plurality of pump heads, a multiple channel head can be used, along with additional pump heads that can be multiple channel and/or single channel.
  • Embodiments of the invention can utilize a variety of tubing sizes and/or tubing materials, and suitable sizes and materials are known to one of skill in the art.
  • The diafiltration distribution plate can be formed of various materials known in the art, including, for example, polymeric materials such as polypropylene.
  • A variety of arrangements for cross fluid treatment assemblies comprising UF membranes between feed sides (feed channels) and permeate sides (permeate channels) are suitable for use in the invention. Typically, the feed channels and permeate channels include spacer materials and/or perforate materials such as screens or meshes. The screens or meshes can have any suitable size openings, e.g., fine, medium, or coarse size openings.
  • A cross fluid treatment assembly can have any number of membranes, feed channels, and permeate channels, including, for example, those disclosed in U.S. Pat. No. 8,980,088. FIG. 2B illustrates an exemplary cross fluid treatment assembly 550 comprising 4 UF membranes (560, 560′, 560″, 560″), wherein each membrane is arranged between a permeate channel (562, 562′, 562″) and a feed channel (561, 561′). If desired, cross fluid treatment assembly components can be combined to provide cross fluid treatment sub-assemblies, e.g., wherein a permeate channel and a membrane are combined to form a permeate channel/membrane sub-assembly. For example, FIG. 2C shows top, middle, and bottom permeate channel/membrane sub-assemblies 550-1, 550-2, and 550-3, respectively, and a feed channel is arranged between the top and middle sub-assembly, and another feed channel is arranged between the middle sub-assembly and the bottom sub-assembly. FIG. 2C shows various seals associated with various cross fluid treatment components, illustrated as feed channel seals 561 a′, 561 a″, 561a′, 561a″, and permeate channel seals 562 a′, 562 a″.
  • In accordance with an embodiment of the invention, the UF membrane can be formed from any of numerous materials, including those known in the art, including, for example, a natural or synthetic polymer, including, e.g., regenerated cellulose, polyethersulfone, etc. The membrane can be supported or unsupported.
  • The membrane can have any suitable pore structure, e.g., a wide range of molecular cutoffs (such as, e.g., 10 kDa, 30 kDa, etc.) or removal ratings. Suitable membranes include those known in the art.
  • Further, the membrane may have, or may be modified to have, any of a myriad of fluid treatment characteristics. For example, the membrane may have a positive, negative, or neutral electrical charge; it may be liquiphobic or liquiphilic, including hydrophobic or hydrophilic or oleophobic or oleophilic; and/or it may have attached functional groups, such as ligands or any other reactive moiety, that can chemically bind to substances in the fluid. The membrane may be formed from, impregnated with, or otherwise contain a variety of materials that function to further treat the fluid in any of numerous ways. These functional materials may include, for example, sorbents, ion exchange resins, chromatography media, enzymes, reactants, or catalysts of all types that may chemically and/or physically bind, react with, catalyze, deliver, or otherwise affect substances in the fluid or the fluid itself
  • The membrane can have any desired critical wetting surface tension (CWST, as defined in, for example, U.S. Pat. No. 4,925,572). The CWST can be selected as is known in the art, e.g., as additionally disclosed in, for example, U.S. Pat. Nos. 5,152,905, 5,443,743, 5,472,621, and 6,074,869.
  • The following examples, that are all operated in a co-current manner (FIGS. 2D and 4C show fluid flow pathways through the assemblies when operated in a co-current manner), further illustrate the invention but, of course, should not be construed as in any way limiting its scope.
  • The examples show that flow rate distribution through the fluid treatment assemblies is generally uniform, and manageable through a single point of control, while providing a desired level of removal efficiency.
  • EXAMPLE 1
  • This example demonstrates achieving 99% (2-log; NDV=7) removal of impurities from feed streams having two different feed fluid flow rates (10 mL/min and 20 mL/min), with controlled diafiltration fluid flow rates (in each channel), in accordance with embodiments of the invention.
  • A diafiltration system is set up including a fluid treatment assembly as generally shown in FIG. 4 (A and B), wherein the diafiltration pump and diafiltration system are arranged as generally shown in FIGS. 1A and 1C, including a MASTERFLEX L/S Precision Variable Speed Pump Drive (Model No: EW-07528-30), with three MASTERFLEX L/S Multi-channel Pump Heads (Model No: 07536-002) and MASTERFLEX L/S High Performance Precision 2-stop tubing sets (L/S 15, 06421-15) (Cole-Palmer Instrument Company, Vernon Hills, Ill.).
  • The fluid treatment assembly has 6 stages, each stage having 2-in-series cross fluid treatment assemblies, each cross fluid treatment assembly including Delta regenerated cellulose UF membranes, each with a 30 kDa cutoff and a surface area of 186 cm2 (total membrane area for the fluid treatment assembly is 2232 cm2).
  • The feed solution is 10 g/L polyclonal bovine IgG in 0.025 M sodium acetate plus 0.5 M sodium chloride (NaCl) (conductivity 47 mS/cm). The diafiltration (DF) solution (buffer solution) is 0.025 M sodium acetate plus 0.05 M NaCl (conductivity 6.7 mS/cm).
  • When the feed fluid flow rate is 10 mL/min, the diafiltration fluid flow rate in each channel is about 11.7 mL/min, and when the feed fluid flow rate is 20 mL/min, the diafiltration fluid flow rate in each channel is about 23.3 mL/min.
  • An approximate 1:1 ratio is maintained between the feed flow rate and the retentate flow rate by using retentate throttling.
  • The results are as follows:
  • For fluid flow rates of 10 mL/min, the flow rate distribution per DF stage remains generally uniform around 10 mL/min. The distribution of pressures remain generally uniform around 12 psig for DF stages 1-3, decreasing toward the retentate outlet from about 9 psig to about 4 psig for DF stages 4-6.
  • For fluid flow rates of 20 mL/min, the flow rate distribution per DF stage remains generally uniform around 18-20 mL/min. The distribution of pressures remain generally uniform around 28 psig for DF stages 1-3, decreasing toward the retentate outlet from about 25 psig to about 9 psig for DF stages 4-6.
  • EXAMPLE 2
  • This example demonstrates achieving 99.9% (3-log; NDV=13) removal of impurities from feed streams having two different feed fluid flow rates (5 mL/min and 10 mL/min), with controlled diafiltration fluid flow rates (in each channel), in accordance with embodiments of the invention.
  • The diafiltration system, fluid treatment assembly, and feed and DF solutions are as described in Example 1.
  • When the feed fluid flow rate is 5 mL/min, the diafiltration fluid flow rate in each channel is about 10.8 mL/min, and when the feed fluid flow rate is 10 mL/min, the diafiltration fluid flow rate in each channel is about 22.7 mL/min.
  • An approximate 1:1 ratio is maintained between the feed flow rate and the retentate flow rate by using retentate throttling.
  • The results are as follows:
  • For feed fluid flow rates of 5 mL/min, the flow rate distribution per DF stage remains generally uniform around 10 mL/min for DF stages 1-6. The pressures at DF stages 1 and 2 are 15 psig and 17 psig, respectively, the distribution of pressures remain generally uniform around 20 psig for DF stages 3-5, and decrease to about 15 psig for DF stage 6.
  • For feed fluid flow rates of 10 mL/min, the flow rate distribution per DF stage is in the range of around 11-9 mL/min for DF stages 2-4, and around 7 psig for DF stages 5 and 6. The distribution of pressures ranges from around 34 psig for DF stage 1, decreasing about 1 to 2 psig per stage toward the retentate outlet to about 25 psig for DF stage 6.
  • With respect to the feed flow rate of 5 mL/min in particular, both the pressure and flow rate management is relatively easy and uniform for targeting the 99.9% removal efficiency.
  • EXAMPLE 3
  • This example demonstrates achieving 99.99% (4-log; NDV=22) removal of impurities from feed streams having a fluid flow rate 5 mL/min, with controlled diafiltration fluid flow rates (in each channel) of about 18.3 mL/min, in accordance with an embodiment of the invention.
  • The diafiltration system, fluid treatment assembly, and feed and DF solutions are as described in Example 1.
  • An approximate 1:1 ratio is maintained between the feed flow rate and the retentate flow rate by using retentate throttling.
  • The results are as follows:
  • The flow rate distribution per DF stage remains in the range of around 8-12 mL/min for DF stages 1-6. The distribution of pressures ranges from around 34 psig for DF stage 1, decreasing about 1 to 2 psig per stage toward the retentate outlet to about 26 psig for DF stage 6.
  • EXAMPLE 4
  • This example demonstrates achieving 99.0% (2-log; NDV=7) removal of impurities from feed streams having feed fluid flow rates of 10 mL/min, and achieving 99.9% (3-log; NDV=13) removal of impurities from feed streams having feed fluid flow rates of 6 mL/min, with controlled diafiltration fluid flow rates (in each channel), in accordance with embodiments of the invention.
  • A diafiltration system is set up including a fluid treatment assembly as generally described in Example 1.
  • The fluid treatment assembly has 6 stages, each stage having 3-in-series cross fluid treatment assemblies, each cross fluid treatment assembly including Delta regenerated cellulose UF membranes, each with a 30 kDa cutoff and a surface area of 186 cm2.
  • The feed solution is 60 g/L polyclonal bovine IgG in 0.025 M sodium acetate plus 0.5 M sodium chloride (NaCl) (conductivity 47 mS/cm). The diafiltration (DF) solution (buffer solution) is 0.025 M sodium acetate plus 0.05 M NaCl (conductivity 6.7 mS/cm).
  • When the feed fluid flow rate is 10 mL/min, the diafiltration fluid flow rate in each channel is about 11.7 mL/min, and when the feed fluid flow rate is 6 mL/min, the diafiltration fluid flow rate in each channel is about 13 mL/min.
  • An approximate 1:1 ratio is maintained between the feed flow rate and the retentate flow rate by using retentate throttling.
  • The results are as follows:
  • For feed fluid flow rates of 10 mL/min, the flow rate at DF stage 1 is about 6 mL/min, at DF stage 2 is about 7 mL/min, remaining uniform at about 10 mL/min for DF stages 3-6. The pressures at DF stages 1-6 are 33 psig, 31 psig, 28 psig, 16 psig, 11 psig, and 8 psig, respectively.
  • For feed fluid flow rates of 6 mL/min, the flow rate at DF stage 1 is 4 mL/min, at DF stage 2 is about 8 mL/min, remaining uniform at about 10 mL/min for DF stages 3-5, and about 12 mL/min for DF stage 6. The pressures at DF stages 1-6 are 29 psig, 28 psig, 24 psig, 15 psig, 10 psig, and 8 psig, respectively.
  • Both the pressure and flow rate management is successful and robust for the various target removal efficiencies and feed flow rates.
  • EXAMPLE 5
  • This example illustrates testing utilizing diafiltration markers for better quantification of target percent removal efficiencies.
  • The fluid treatment assembly is as described in Example 4.
  • The feed solution is 60 g/L polyclonal bovine IgG with glucose as a representative small molecule. The feed solution is 60 g/L IgG in 0.025 M Na Acetate plus 0.05 M NaCl plus 50 g/L glucose (conductivity 6.7 mS/cm). The DF solution (buffer solution) is 0.025 M Na Acetate plus 0.05 M NaCl (conductivity 6.7 mS/cm).
  • The results are as follows: 99.9% (3-log; NDV=13) removal of glucose molecule as the small impurity having feed fluid flow rate of 5 mL/min, with controlled diafiltration fluid flow rates (in each channel). The detection limit of the glucose is 0.03 g/L.
  • All references, including publications, patent applications, and patents, cited herein are hereby incorporated by reference to the same extent as if each reference were individually and specifically indicated to be incorporated by reference and were set forth in its entirety herein.
  • The use of the terms “a” and “an” and “the” and “at least one” and similar referents in the context of describing the invention (especially in the context of the following claims) are to be construed to cover both the singular and the plural, unless otherwise indicated herein or clearly contradicted by context. The use of the term “at least one” followed by a list of one or more items (for example, “at least one of A and B”) is to be construed to mean one item selected from the listed items (A or B) or any combination of two or more of the listed items (A and B), unless otherwise indicated herein or clearly contradicted by context. The terms “comprising,” “having,” “including,” and “containing” are to be construed as open-ended terms (i.e., meaning “including, but not limited to,”) unless otherwise noted. Recitation of ranges of values herein are merely intended to serve as a shorthand method of referring individually to each separate value falling within the range, unless otherwise indicated herein, and each separate value is incorporated into the specification as if it were individually recited herein. All methods described herein can be performed in any suitable order unless otherwise indicated herein or otherwise clearly contradicted by context. The use of any and all examples, or exemplary language (e.g., “such as”) provided herein, is intended merely to better illuminate the invention and does not pose a limitation on the scope of the invention unless otherwise claimed. No language in the specification should be construed as indicating any non-claimed element as essential to the practice of the invention.
  • Preferred embodiments of this invention are described herein, including the best mode known to the inventors for carrying out the invention. Variations of those preferred embodiments may become apparent to those of ordinary skill in the art upon reading the foregoing description. The inventors expect skilled artisans to employ such variations as appropriate, and the inventors intend for the invention to be practiced otherwise than as specifically described herein. Accordingly, this invention includes all modifications and equivalents of the subject matter recited in the claims appended hereto as permitted by applicable law. Moreover, any combination of the above-described elements in all possible variations thereof is encompassed by the invention unless otherwise indicated herein or otherwise clearly contradicted by context.

Claims (18)

1. A diafiltration system comprising
(a) a fluid treatment assembly comprising two or more fluid treatment modules, the fluid treatment assembly comprising a feed inlet, a permeate outlet, and a retentate outlet;
(i) each fluid treatment module comprising a cross flow treatment assembly including at least one ultrafiltration membrane, the cross flow treatment assembly having at least one feed side and at least one opposite permeate side, and a diafiltration fluid distribution plate comprising a diafiltration fluid feed inlet and a common feed permeate/diafiltration fluid permeate outlet port;
(b) two or more separate diafiltration fluid conduits, each separate diafiltration fluid conduit in fluid communication with a respective single diafiltration fluid feed inlet; and,
(c) a diafiltration fluid pump, the diafiltration fluid pump comprising at least a first multiple channel pump head having at least two channels including separate channels for separate diafiltration fluid conduits in fluid communication with respective single diafiltration fluid feed inlets, wherein the diafiltration pump provides simultaneously controlled diafiltration fluid flow rates through each of the separate diafiltration fluid conduits to the respective single diafiltration fluid feed inlets.
2. The diafiltration system of claim 1, including at least one additional channel pump head having including a separate channel for a separate diafiltration fluid conduit in fluid communication with a single diafiltration fluid feed inlet, wherein the pump, via the first multiple channel pump head and the additional channel pump head, provides simultaneously controlled diafiltration fluid flow rates through each of the separate diafiltration fluid conduits to the respective single diafiltration fluid feed inlets.
3. The diafiltration system of claim 1, including at least one additional multiple channel pump head having at least two channels including a separate channel for a separate diafiltration fluid conduit in fluid communication with a single diafiltration fluid feed inlet, wherein the pump, via the first multiple channel pump head and the additional multiple channel pump head, provides simultaneously controlled diafiltration fluid flow rates through each of the separate diafiltration fluid conduits to the respective single diafiltration fluid feed inlets.
4. The diafiltration system of claim 1, further comprising a feed fluid pump and a feed fluid conduit, wherein the feed fluid conduit is in fluid communication with the fluid treatment assembly feed inlet, wherein the feed fluid pump provides a controlled feed fluid flow rate through the feed fluid conduit to the fluid treatment assembly feed inlet.
5. The diafiltration system of claim 1, further comprising a retentate throttling valve, arranged to allow the system to maintain a desired ratio of feed flow rate to retentate flow rate.
6. A diafiltration method, the method comprising passing a feed fluid containing undesirable material and desirable biomolecules, and a diafiltration fluid suitable for washing out undesirable material from the feed fluid, through the fluid treatment assembly in the diafiltration system of claim 1, wherein the method includes
(a) passing the feed fluid at a controlled feed fluid flow rate through the feed inlet of the fluid treatment assembly;
(b) passing the diafiltration fluid at a controlled diafiltration fluid flow rate through each of the separate diafiltration fluid conduits in fluid communication with respective single diafiltration fluid feed inlets, such that the diafiltration fluid washes undesirable material from the feed fluid, wherein the controlled diafiltration fluid flow rate is simultaneously controlled through each of the separate diafiltration fluid conduits;
(c) passing a feed permeate/diafiltration fluid permeate fluid through each of the common feed permeate/diafiltration fluid permeate outlet ports;
(d) passing a retentate fluid from the retentate outlet of fluid treatment assembly, the retentate fluid comprising desirable biomolecules and a lower concentration of undesirable material than the concentration of undesirable material in the feed fluid; and,
(e) passing the feed permeate/diafiltration fluid permeate fluid from the permeate outlet of the fluid treatment assembly.
7. The method of claim 6, comprising passing the feed fluid through the feed inlet at a controlled flow rate that is at least about 10% less than the simultaneously controlled diafiltration fluid flow rates through each of the separate diafiltration fluid conduits.
8. The diafiltration system of claim 2, including at least one additional multiple channel pump head having at least two channels including a separate channel for a separate diafiltration fluid conduit in fluid communication with a single diafiltration fluid feed inlet, wherein the pump, via the first multiple channel pump head and the additional multiple channel pump head, provides simultaneously controlled diafiltration fluid flow rates through each of the separate diafiltration fluid conduits to the respective single diafiltration fluid feed inlets.
9. The diafiltration system of claim 2, further comprising a feed fluid pump and a feed fluid conduit, wherein the feed fluid conduit is in fluid communication with the fluid treatment assembly feed inlet, wherein the feed fluid pump provides a controlled feed fluid flow rate through the feed fluid conduit to the fluid treatment assembly feed inlet.
10. The diafiltration system of claim 3, further comprising a feed fluid pump and a feed fluid conduit, wherein the feed fluid conduit is in fluid communication with the fluid treatment assembly feed inlet, wherein the feed fluid pump provides a controlled feed fluid flow rate through the feed fluid conduit to the fluid treatment assembly feed inlet.
11. A diafiltration method, the method comprising passing a feed fluid containing undesirable material and desirable biomolecules, and a diafiltration fluid suitable for washing out undesirable material from the feed fluid, through the fluid treatment assembly in the diafiltration system of claim 2, wherein the method includes
(a) passing the feed fluid at a controlled feed fluid flow rate through the feed inlet of the fluid treatment assembly;
(b) passing the diafiltration fluid at a controlled diafiltration fluid flow rate through each of the separate diafiltration fluid conduits in fluid communication with respective single diafiltration fluid feed inlets, such that the diafiltration fluid washes undesirable material from the feed fluid, wherein the controlled diafiltration fluid flow rate is simultaneously controlled through each of the separate diafiltration fluid conduits;
(c) passing a feed permeate/diafiltration fluid permeate fluid through each of the common feed permeate/diafiltration fluid permeate outlet ports;
(d) passing a retentate fluid from the retentate outlet of fluid treatment assembly, the retentate fluid comprising desirable biomolecules and a lower concentration of undesirable material than the concentration of undesirable material in the feed fluid; and,
(e) passing the feed permeate/diafiltration fluid permeate fluid from the permeate outlet of the fluid treatment assembly.
12. A diafiltration method, the method comprising passing a feed fluid containing undesirable material and desirable biomolecules, and a diafiltration fluid suitable for washing out undesirable material from the feed fluid, through the fluid treatment assembly in the diafiltration system of claim 3, wherein the method includes
(a) passing the feed fluid at a controlled feed fluid flow rate through the feed inlet of the fluid treatment assembly;
(b) passing the diafiltration fluid at a controlled diafiltration fluid flow rate through each of the separate diafiltration fluid conduits in fluid communication with respective single diafiltration fluid feed inlets, such that the diafiltration fluid washes undesirable material from the feed fluid, wherein the controlled diafiltration fluid flow rate is simultaneously controlled through each of the separate diafiltration fluid conduits;
(c) passing a feed permeate/diafiltration fluid permeate fluid through each of the common feed permeate/diafiltration fluid permeate outlet ports;
(d) passing a retentate fluid from the retentate outlet of fluid treatment assembly, the retentate fluid comprising desirable biomolecules and a lower concentration of undesirable material than the concentration of undesirable material in the feed fluid; and,
(e) passing the feed permeate/diafiltration fluid permeate fluid from the permeate outlet of the fluid treatment assembly.
13. A diafiltration method, the method comprising passing a feed fluid containing undesirable material and desirable biomolecules, and a diafiltration fluid suitable for washing out undesirable material from the feed fluid, through the fluid treatment assembly in the diafiltration system of claim 4, wherein the method includes
(a) passing the feed fluid at a controlled feed fluid flow rate through the feed inlet of the fluid treatment assembly;
(b) passing the diafiltration fluid at a controlled diafiltration fluid flow rate through each of the separate diafiltration fluid conduits in fluid communication with respective single diafiltration fluid feed inlets, such that the diafiltration fluid washes undesirable material from the feed fluid, wherein the controlled diafiltration fluid flow rate is simultaneously controlled through each of the separate diafiltration fluid conduits;
(c) passing a feed permeate/diafiltration fluid permeate fluid through each of the common feed permeate/diafiltration fluid permeate outlet ports;
(d) passing a retentate fluid from the retentate outlet of fluid treatment assembly, the retentate fluid comprising desirable biomolecules and a lower concentration of undesirable material than the concentration of undesirable material in the feed fluid; and,
(e) passing the feed permeate/diafiltration fluid permeate fluid from the permeate outlet of the fluid treatment assembly.
14. A diafiltration method, the method comprising passing a feed fluid containing undesirable material and desirable biomolecules, and a diafiltration fluid suitable for washing out undesirable material from the feed fluid, through the fluid treatment assembly in the diafiltration system of claim 5, wherein the method includes
(a) passing the feed fluid at a controlled feed fluid flow rate through the feed inlet of the fluid treatment assembly;
(b) passing the diafiltration fluid at a controlled diafiltration fluid flow rate through each of the separate diafiltration fluid conduits in fluid communication with respective single diafiltration fluid feed inlets, such that the diafiltration fluid washes undesirable material from the feed fluid, wherein the controlled diafiltration fluid flow rate is simultaneously controlled through each of the separate diafiltration fluid conduits;
(c) passing a feed permeate/diafiltration fluid permeate fluid through each of the common feed permeate/diafiltration fluid permeate outlet ports;
(d) passing a retentate fluid from the retentate outlet of fluid treatment assembly, the retentate fluid comprising desirable biomolecules and a lower concentration of undesirable material than the concentration of undesirable material in the feed fluid; and,
(e) passing the feed permeate/diafiltration fluid permeate fluid from the permeate outlet of the fluid treatment assembly.
15. The method of claim 11, comprising passing the feed fluid through the feed inlet at a controlled flow rate that is at least about 10% less than the simultaneously controlled diafiltration fluid flow rates through each of the separate diafiltration fluid conduits.
16. The method of claim 12, comprising passing the feed fluid through the feed inlet at a controlled flow rate that is at least about 10% less than the simultaneously controlled diafiltration fluid flow rates through each of the separate diafiltration fluid conduits.
17. The method of claim 13, comprising passing the feed fluid through the feed inlet at a controlled flow rate that is at least about 10% less than the simultaneously controlled diafiltration fluid flow rates through each of the separate diafiltration fluid conduits.
18. The method of claim 14, comprising passing the feed fluid through the feed inlet at a controlled flow rate that is at least about 10% less than the simultaneously controlled diafiltration fluid flow rates through each of the separate diafiltration fluid conduits.
US15/015,350 2016-02-04 2016-02-04 Inline diafiltration with multi-channel pump Active 2037-03-19 US10183108B2 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
US15/015,350 US10183108B2 (en) 2016-02-04 2016-02-04 Inline diafiltration with multi-channel pump
EP17151017.5A EP3202484B1 (en) 2016-02-04 2017-01-11 Inline diafiltration with multi-channel pump
JP2017003672A JP6402375B2 (en) 2016-02-04 2017-01-12 In-line diafiltration with multi-channel pump
SG10201700425WA SG10201700425WA (en) 2016-02-04 2017-01-18 Inline diafiltration with multi-channel pump
AU2017200496A AU2017200496B2 (en) 2016-02-04 2017-01-25 Inline diafiltration with multi-channel pump
CN201710056870.4A CN107029556B (en) 2016-02-04 2017-01-26 Percolation system and method
CA2956615A CA2956615C (en) 2016-02-04 2017-01-31 Inline diafiltration with multi-channel pump
KR1020170013716A KR101917663B1 (en) 2016-02-04 2017-01-31 Inline diafiltration with multi-channel pump

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15/015,350 US10183108B2 (en) 2016-02-04 2016-02-04 Inline diafiltration with multi-channel pump

Publications (2)

Publication Number Publication Date
US20170225123A1 true US20170225123A1 (en) 2017-08-10
US10183108B2 US10183108B2 (en) 2019-01-22

Family

ID=58009662

Family Applications (1)

Application Number Title Priority Date Filing Date
US15/015,350 Active 2037-03-19 US10183108B2 (en) 2016-02-04 2016-02-04 Inline diafiltration with multi-channel pump

Country Status (8)

Country Link
US (1) US10183108B2 (en)
EP (1) EP3202484B1 (en)
JP (1) JP6402375B2 (en)
KR (1) KR101917663B1 (en)
CN (1) CN107029556B (en)
AU (1) AU2017200496B2 (en)
CA (1) CA2956615C (en)
SG (1) SG10201700425WA (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019191627A1 (en) 2018-03-30 2019-10-03 Insmed Incorporated Methods for continuous manufacture of liposomal drug products
US20230201446A1 (en) * 2019-05-21 2023-06-29 Covidien Lp Peristaltic pumps with selective activation of multiple fluid lines and fluid management systems including the same
US12016873B2 (en) 2014-05-15 2024-06-25 Insmed Incorporated Methods for treating pulmonary non-tuberculous mycobacterial infections
WO2024249582A1 (en) * 2023-06-02 2024-12-05 Sanofi Pasteur Inc. Systems and devices for filtering biological products and methods of using the same
EP4523717A3 (en) * 2018-05-18 2025-04-23 The Regents of The University of California In vivo blood filtration membranes and devices

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7653244B2 (en) * 2019-11-13 2025-03-28 ノリタケ株式会社 Ultrafiltration unit for continuous purification and method for producing protein using the ultrafiltration unit for continuous purification
WO2021150649A1 (en) * 2020-01-21 2021-07-29 Membrane Technology And Research, Inc. Crossflow membrane module
JP7667300B2 (en) * 2021-03-08 2025-04-22 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Systems and methods for single-pass countercurrent diafiltration

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4925572A (en) 1987-10-20 1990-05-15 Pall Corporation Device and method for depletion of the leukocyte content of blood and blood components
US5152905A (en) 1989-09-12 1992-10-06 Pall Corporation Method for processing blood for human transfusion
US5443743A (en) 1991-09-11 1995-08-22 Pall Corporation Gas plasma treated porous medium and method of separation using same
CA2083075A1 (en) 1992-06-10 1993-12-11 Vlado I. Matkovich System for treating transition zone material
EP0772484B1 (en) 1994-07-28 2008-02-27 Pall Corporation Fibrous web and process of preparing same
US5616595A (en) 1995-06-07 1997-04-01 Abbott Laboratories Process for recovering water insoluble compounds from a fermentation broth
JP3371783B2 (en) 1997-12-11 2003-01-27 栗田工業株式会社 Cell isolation method
US6214221B1 (en) 1999-02-22 2001-04-10 Henry B. Kopf Method and apparatus for purification of biological substances
US6607669B2 (en) 2000-06-23 2003-08-19 Scilog, Inc. Method and apparatus for enhancing filtration yields in tangential flow filtration
US6645380B2 (en) 2001-12-19 2003-11-11 Petro Sep International Ltd. Membrane separation apparatus
CN2600159Y (en) 2002-11-28 2004-01-21 华南理工大学 Electric ultrafiltration-liquation crystallization device for separating and purifying large biological molecule
US7795010B2 (en) 2004-01-21 2010-09-14 Toray Industries, Inc. Fractionator and method of fractionation
US7410587B2 (en) 2004-08-03 2008-08-12 Scilog, Inc. Liquid handling for filtration and preparative chromatography
US20060043021A1 (en) * 2004-09-02 2006-03-02 Millipore Corporation Port adapter for tangential flow filtration
US7384549B2 (en) 2005-12-29 2008-06-10 Spf Innovations, Llc Method and apparatus for the filtration of biological solutions
US20080135499A1 (en) 2006-12-11 2008-06-12 Pall Corporation Filtration assemblies and methods of maintaining compression of filtration units in filtration assemblies
US7918999B2 (en) 2006-12-11 2011-04-05 Pall Corporation Filtration assemblies, filtration manifolds, filtration units, and methods of channeling permeate
US7988859B2 (en) 2009-02-05 2011-08-02 Chromatan Inc. Countercurrent tangential chromatography methods, systems, and apparatus
US8980088B2 (en) 2011-04-19 2015-03-17 Pall Corporation Fluid treatment arrangements and methods of making fluid treatment arrangements
WO2012171030A2 (en) 2011-06-10 2012-12-13 Biovest International, Inc. Method and apparatus for antibody production and purification
KR101536769B1 (en) 2011-08-12 2015-07-14 폴 코포레이션 Fluid treatment assemblies, manifolds for fluid treatment assemblies, and methods for treating fluids
US9802161B2 (en) 2011-11-10 2017-10-31 Pall Corporation Fluid treatment assemblies
DE102012204011A1 (en) * 2012-03-14 2013-09-19 Bwt Ag Method for operating a membrane separation device, control device for a membrane separation device and device for controlling and / or controlling a membrane separation device
US20140042072A1 (en) 2012-08-10 2014-02-13 Pall Corporation Fluid treatment assemblies, fluid treatment segments, and methods of making fluid treatment systems
US10585095B2 (en) 2013-07-19 2020-03-10 Circle Technologies, Inc. Systems and methods for bioprocess analysis
WO2015195452A2 (en) 2014-06-16 2015-12-23 Emd Millipore Corporation Single-pass filtration systems and processes
KR101938948B1 (en) 2014-06-25 2019-01-15 이엠디 밀리포어 코포레이션 Compact spiral-wound filter elements, modules and systems
WO2016033546A1 (en) 2014-08-29 2016-03-03 Emd Millipore Corporation Single pass tangential flow filtration systems and tangential flow filtration systems with recirculation of retentate
WO2016033553A1 (en) 2014-08-29 2016-03-03 Emd Millipore Corporation Processes for filtering liquids using single pass tangential flow filtration systems and tangential flow filtration systems with recirculation of retentate

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12016873B2 (en) 2014-05-15 2024-06-25 Insmed Incorporated Methods for treating pulmonary non-tuberculous mycobacterial infections
US12168022B2 (en) 2014-05-15 2024-12-17 Insmed Incorporated Methods for treating pulmonary non-tuberculous mycobacterial infections
US12168021B2 (en) 2014-05-15 2024-12-17 Insmed Incorporated Methods for treating pulmonary non-tuberculous mycobacterial infections
US12377114B2 (en) 2014-05-15 2025-08-05 Insmed Incorporated Methods for treating pulmonary non-tuberculous mycobacterial infections
WO2019191627A1 (en) 2018-03-30 2019-10-03 Insmed Incorporated Methods for continuous manufacture of liposomal drug products
US12290600B2 (en) 2018-03-30 2025-05-06 Insmed Incorporated Methods for continuous manufacture of liposomal drug products
EP4523717A3 (en) * 2018-05-18 2025-04-23 The Regents of The University of California In vivo blood filtration membranes and devices
US20230201446A1 (en) * 2019-05-21 2023-06-29 Covidien Lp Peristaltic pumps with selective activation of multiple fluid lines and fluid management systems including the same
WO2024249582A1 (en) * 2023-06-02 2024-12-05 Sanofi Pasteur Inc. Systems and devices for filtering biological products and methods of using the same

Also Published As

Publication number Publication date
CN107029556A (en) 2017-08-11
AU2017200496A1 (en) 2017-08-24
KR20170093070A (en) 2017-08-14
AU2017200496B2 (en) 2021-02-25
CN107029556B (en) 2020-03-03
US10183108B2 (en) 2019-01-22
CA2956615A1 (en) 2017-08-04
EP3202484A1 (en) 2017-08-09
EP3202484B1 (en) 2020-05-06
JP2017200691A (en) 2017-11-09
JP6402375B2 (en) 2018-10-10
SG10201700425WA (en) 2017-09-28
CA2956615C (en) 2020-07-07
KR101917663B1 (en) 2018-11-12

Similar Documents

Publication Publication Date Title
US10183108B2 (en) Inline diafiltration with multi-channel pump
US11565215B2 (en) Permeate channel alterations for counter current filtration for use in cross-flow filtration modules useful in osmotic systems
EP3185996B1 (en) Single pass tangential flow filtration systems and tangential flow filtration systems with recirculation of retentate
US12201925B2 (en) Processes for filtering liquids using single pass tangential flow filtration systems and tangential flow filtration systems with recirculation of retentate
US8231787B2 (en) Tangential flow filtration system
JP4688421B2 (en) Water purification system and method, and module for said system
US11612861B2 (en) Crossflow filtration unit for continuous diafiltration
US8048315B2 (en) Fluid treatment arrangements and methods
JP5927706B2 (en) Fluid processing assembly, manifold for fluid processing assembly, and method for processing fluid
Güler et al. Integrated solution for boron removal from seawater using RO process and sorption-membrane filtration hybrid method
CN110636894B (en) Osmotic pressure assisted reverse osmosis membrane and module
US20190168162A1 (en) Filtration assembly and filtration system including the same
KR101404984B1 (en) Manifold plates and fluid treatment arrangements including manifold plates
US20020038782A1 (en) Plate-and -frame type membrane module system with inserted durable balls using vortex flow
KR100658423B1 (en) Multi-stage Separation System by Reverse Osmosis Membrane
CN221131706U (en) Online continuous concentration washing and filtering system
WO2023187064A1 (en) Separation system for separating and purifying a target component
WO2025040897A1 (en) Feed spacer for a spiral wound membrane
RU2487747C1 (en) Membrane device
CN120529952A (en) Tangential flow filter with combined permeate output and filtration method
Borriello et al. Transient permeation of butanes through zeolite membranes

Legal Events

Date Code Title Description
AS Assignment

Owner name: PALL CORPORATION, NEW YORK

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:AYTURK, ENGIN;CASEY, CATHERINE;SIGNING DATES FROM 20160203 TO 20160206;REEL/FRAME:040921/0860

AS Assignment

Owner name: PALL CORPORATION, NEW YORK

Free format text: CORRECTION BY DECLARATION OF INCORRECT NUMBER 29553358 RECORDED AT REEL/FRAME 037740/0577;ASSIGNOR:PALL CORPORATION;REEL/FRAME:042051/0461

Effective date: 20160203

STCF Information on status: patent grant

Free format text: PATENTED CASE

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1551); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

Year of fee payment: 4

AS Assignment

Owner name: CYTIVA US LLC, MASSACHUSETTS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:PALL CORPORATION;REEL/FRAME:063144/0716

Effective date: 20230101

Owner name: CYTIVA US LLC, MASSACHUSETTS

Free format text: ASSIGNMENT OF ASSIGNOR'S INTEREST;ASSIGNOR:PALL CORPORATION;REEL/FRAME:063144/0716

Effective date: 20230101